Product Information

CLONAZEPAM 0.5 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0198 per EA under NDC 16729013616. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on May 2, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLONAZEPAM 0.5 MG TABLET

clonazepam
$0.0198per EA
DEA Schedule CIV

Strength

.5 mg/1

NDC

16729013616

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CLONAZEPAM

Approval Type

Generic (ANDA)

FDA Application

ANDA077147

FDA Approved

5/2/2005

TE Code

AB

On Market Since

6/3/2011

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for CLONAZEPAM 0.5 MG TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has risen 21.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0198 per EA
All-time high$0.0302 (Jul 12, 2023)
All-time low$0.0154 (Jan 18, 2017)
52-week high$0.0223
52-week low$0.0196
Median price$0.0209
Average price$0.0211
Largest weekly change-34.1% (Nov 20, 2024)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+0.6%

1M

+0.6%

3M

+0.2%

6M

+0.1%

1Y

-11.4%

3Y

-24.6%

5Y

-24.7%

All

+21.1%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLONAZEPAM 0.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 0.5 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0198 per EA (NDC 16729013616), effective Nov 18, 2026.

How has the price of CLONAZEPAM 0.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for CLONAZEPAM 0.5 MG TABLET has risen 21.1%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CLONAZEPAM 0.5 MG TABLET?

Since Nov 28, 2013, the NADAC for CLONAZEPAM 0.5 MG TABLET has ranged from a low of $0.0154 (Jan 18, 2017) to a high of $0.0302 (Jul 12, 2023), with a median of $0.0209 per EA.

Are there cheaper alternatives to CLONAZEPAM 0.5 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLONAZEPAM 0.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CLONAZEPAM 0.5 MG TABLET?

CLONAZEPAM 0.5 MG TABLET (NDC 16729013616) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.